A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics

Contemporary Clinical Trials

Volumn 47, Issue , 2016, Pages 12-21

  Nollen, Nicole L ^a   Cox, Lisa Sanderson ^a   Yu, Qing ^a   Ellerbeck, Edward F ^a   Scheuermann, Taneisha S ^a   Benowitz, Neal L ^b,c   Tyndale, Rachel F ^d,e   Mayo, Matthew S ^a   Ahluwalia, Jasjit S ^f  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

African American; Disparities; Smoking cessation; Varenicline; White

Indexed keywords

COTININE; VARENICLINE; NICOTINIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; ETHNIC DIFFERENCE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; RACE DIFFERENCE; SMOKING; SMOKING CESSATION; SOCIAL STATUS; TOBACCO DEPENDENCE; COHORT ANALYSIS; ETHNOLOGY; FEMALE; HEALTH DISPARITY; MALE; PROCEDURES; PROSPECTIVE STUDY; TOBACCO USE DISORDER; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; COHORT STUDIES; COUNSELING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; NICOTINIC AGONISTS; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; VARENICLINE;

EID: 84949651114     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.12.001     Document Type: Article

References (95)

1. Centers for Disease Control and Prevention Tobacco Control State Highlights, 2010 2010, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta.
2. Trinidad D.R., Perez-Stable E.J., Emery S.L., White M.M., Grana R.A., Messer K.S. Intermittent and light daily smoking across racial/ethnic groups in the United States. Nicotine Tob. Res. 2009, 11(2):203-210. 10.1093/ntr/ntn018.
3. Trinidad D.R., Perez-Stable E.J., White M.M., Emery S.L., Messer K. A nationwide analysis of US racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors. Am. J. Public Health 2011, 101(4):699-706. 10.2105/AJPH.2010.191668.
4. American Cancer Society Cancer Facts & Figures for African-Americans 2013-2014 2013, American Cancer Society, Atlanta, GA.
5. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Blaha M.J., et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129(3):e28-e292. 10.1161/01.cir.0000441139.02102.80.
6. Liao Y., McGee D.L., Cooper R.S. Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts. Am. J. Cardiol. 1999, 84(1):31-36. (doi:S0002-9149(99)00187-3 [pii]).
7. Haiman C.A., Stram D.O., Wilkens L.R., Pike M.C., Kolonel L.N., Henderson B.E., et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N. Engl. J. Med. 2006, 354(4):333-342.
8. Rosenberg L., Palmer J.R., Rao R.S., Adams-Campbell L.L. Risk factors for coronary heart disease in African-American women. Am. J. Epidemiol. 1999, 150(9):904-909.
9. Perez-Stable E.J., Herrera B., Jacob P., Benowitz N.L. Nicotine metabolism and intake in black and white smokers. J. Am. Med. Assoc. 1998, 280(2):152-156.
10. Benowitz N.L., Dains K.M., Dempsey D., Wilson M., Jacob P. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob Res. 2011, ([pii]). 10.1093/ntr/ntr072.
11. Clark P.I., Gautam S., Gerson L.W. EFfect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. Chest 1996, 110(5):1194-1198. 10.1378/chest.110.5.1194.
12. Fu S.S., Kodl M.M., Joseph A.M., Hatsukami D.K., Johnson E.O., Breslau N., et al. Racial/ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44years. Cancer Epidemiol. Biomark. Prev. 2008, 17(7):1640-1647. 10.1158/1055-9965.epi-07-2726.
13. Doescher M.P., Saver B.G. Physicians' advice to quit smoking. The glass remains half empty. J. Fam. Pract. 2000, 49(6):543-547.
14. Hymowitz N., Jackson J., Carter R., Eckholdt H. Past quit smoking assistance and doctors' advice for white and African-American smokers. J. Natl. Med. Assoc. 1996, 88(4):249-252.
15. Lopez-Quintero C., Crum R.M., Neumark Y.D. Racial/ethnic disparities in report of physician-provided smoking cessation advice: analysis of the 2000 National Health Interview Survey. Am. J. Public Health 2006, 96(12):2235-2239. ([pii]). 10.2105/AJPH.2005.071035.
16. Zhu S., Melcer T., Sun J., Rosbrook B., Pierce J.P. Smoking cessation with and without assistance: a population-based analysis. Am. J. Prev. Med. 2000, 18(4):305-311.
17. Cokkinides V.E., Halpern M.T., Barbeau E.M., Ward E., Thun M.J. Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am. J. Prev. Med. 2008, 34(5):404-412.
18. Fu S.S., Sherman S.E., Yano E.M., van Ryn M., Lanto A.B., Joseph A.M. Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am. J. Health Promot. 2005, 20(2):108-116.
19. Croghan I.T., Hurt R.D., Ebbert J.O., Croghan G.A., Polk O.D., Stella P.J., et al. Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States. J. Public Health 2010, 18(1):59-68. 10.1007/s10389-009-0277-2.
20. Cropsey K.L., Weaver M.F., Eldridge G.D., Villalobos G.C., Best A.M., Stitzer M.L. Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob. Res. 2009, 11(6):690-697.
21. Gariti P., Lynch K., Alterman A., Kampman K., Xie H., Varillo K. Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking. J. Subst. Abus. Treat. 2009, 37(3):247-255. 10.1016/j.jsat.2009.01.006.
22. Murray R.P., Connett J.E., Buist A.S., Gerald L.B., Eichenhorn M.S. Experience of Black participants in the Lung Health Study smoking cessation intervention program. Nicotine Tob. Res. 2001, 3(4):375-382.
23. Burgess D.J., van Ryn M., Noorbaloochi S., Clothier B., Taylor B.C., Sherman S., et al. Smoking cessation among African-American and White smokers in the Veterans Affairs health care system. Am. J. Public Health 2014, 104(Suppl. 4):S580-S587. 10.2105/AJPH.2014.302023.
24. Kendzor D.E., Businelle M.S., Costello T.J., Castro Y., Reitzel L.R., Cofta-Woerpel L.M., et al. Financial strain and smoking cessation among racially/ethnically diverse smokers. Am. J. Public Health 2010, 100(4):702-706. 10.2105/AJPH.2009.172676.
25. Ahluwalia J.S., Okuyemi K., Nollen N., Choi W.S., Kaur H., Pulvers K., et al. The effects of nicotine gum and counseling among African-American light smokers: a 2×2 factorial design. Addiction 2006, 101(6):883-891. 10.1111/j.1360-0443.2006.01461.x.
26. Benowitz N., Jacob P., Ahijevych K., Jarvis M., Hall S., Hansson A., et al. Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002, 4(2):149-159.
27. Cox L.S., Nollen N.L., Mayo M.S., Choi W.S., Faseru B., Benowitz N.L., et al. Bupropion for smoking cessation in African-American light smokers: a randomized controlled trial. J. Natl. Cancer Inst. 2012, 104(4):290-298. 10.1093/jnci/djr513.
28. Wagenknecht L.E., Burke G.L., Perkins L.L., Haley N.J., Friedman G.D. Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am. J. Public Health 1992, 82(1):33-36.
29. Businelle M.S., Kendzor D.E., Reitzel L.R., Costello T.J., Cofta-Woerpel L., Li Y., et al. Mechanisms linking socioeconomic status to smoking cessation: a structural equation modeling approach. Health Psychol. 2010, 29(3):262-273. 10.1037/a0019285.
30. Castro Y., Cano M.A., Businelle M.S., Correa-Fernandez V., Heppner W.L., Mazas C.A., et al. A cross-lagged path analysis of five intrapersonal determinants of smoking cessation. Drug Alcohol Depend. 2014, 137:98-105. 10.1016/j.drugalcdep.2014.01.013.
31. Cropsey K.L., Clark C.B., Zhang X.N., Hendricks P.S., Jardin B.F., Lahti A.C. Race and medication adherence moderate cessation outcomes in criminal justice smokers. Am. J. Prev. Med. 2015, 10.1016/j.amepre.2015.03.014.
32. Agaku I.T., King B.A., Dube S.R. Centers for disease C, prevention. Current cigarette smoking among adults - United States, 2005-2012. MMWR Morb. Mortal. Wkly Rep. 2014, 63(2):29-34.
33. Kotz D., West R. Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob. Control. 2009, 18(1):43-46.
34. Pierce J.P., White M.M., Messer K. Changing age-specific patterns of cigarette consumption in the United States, 1992-2002: association with smoke-free homes and state-level tobacco control activity. Nicotine Tob. Res. 2009, 11(2):171-177.
35. Piper M.E., Cook J.W., Schlam T.R., Jorenby D.E., Smith S.S., Bolt D.M., et al. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob. Res. 2010, 12(6):647-657. 10.1093/ntr/ntq067.
36. Siahpush M., Carlin J.B. Financial stress, smoking cessation and relapse: results from a prospective study of an Australian national sample. Addiction 2006, 101(1):121-127.
37. Siahpush M., Yong H.H., Borland R., Reid J.L., Hammond D. Smokers with financial stress are more likely to want to quit but less likely to try or succeed: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction 2009, 104(8):1382-1390.
38. Wetter D.W., Kenford S.L., Smith S.S., Fiore M.C., Jorenby D.E., Baker T.B. Gender differences in smoking cessation. J. Consult. Clin. Psychol. 1999, 67(4):555-562.
39. Caraballo R.S., Giovino G.A., Pechacek T.F., Mowery P.D., Richter P.A., Strauss W.J., et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. J. Am. Med. Assoc. 1998, 280(2):135-139.
40. Gandhi K.K., Foulds J., Steinberg M.B., Lu S.E., Williams J.M. Lower quit rates among African-American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int. J. Clin. Pract. 2009, 63(3):360-367.
41. Gundersen D.A., Delnevo C.D., Wackowski O. Exploring the relationship between race/ethnicity, menthol smoking, and cessation, in a nationally representative sample of adults. Prev. Med. 2009, 49(6):553-557.
42. Perez-Stable E.J., Herrera B., Jacob P., Benowitz N.L. Nicotine metabolism and intake in black and white smokers. J. Am. Med. Assoc. 1998, 280(2):152-156.
43. Nollen N.L., Mayo M.S., Ahluwalia J.S., Tyndale R.F., Benowitz N.L., Faseru B., et al. Factors associated with discontinuation of bupropion and counseling among African-American light smokers in a randomized clinical trial. Ann. Behav. Med. 2013, 46(3):336-348. 10.1007/s12160-013-9510-x.
44. Catley D., Ahluwalia J.S., Resnicow K., Nazir N. Depressive symptoms and smoking cessation among inner-city African-Americans using the nicotine patch. Nicotine Tob. Res. 2003, 5(1):61-68. (doi:CDLTHMGVLB7C9AYV [pii]).
45. Catley D., Harris K.J., Okuyemi K.S., Mayo M.S., Pankey E., Ahluwalia J.S. The influence of depressive symptoms on smoking cessation among African-Americans in a randomized trial of bupropion. Nicotine Tob. Res. 2005, 7(6):859-870. (HX31847128412012 [pii]). 10.1080/14622200500330118.
46. Borrelli B., Bock B., King T., Pinto B., Marcus B.H. The impact of depression on smoking cessation in women. Am. J. Prev. Med. 1996, 12(5):378-387.
47. Kendzor D.E., Businelle M.S., Reitzel L.R., Rios D.M., Scheuermann T.S., Pulvers K., et al. Everyday discrimination is associated with nicotine dependence among African-American, Latino, and White smokers. Nicotine Tob. Res. 2014, 16(6):633-640. 10.1093/ntr/ntt198.
48. Kendzor D.E., Reitzel L.R., Mazas C.A., Cofta-Woerpel L.M., Cao Y., Ji L., et al. Individual- and area-level unemployment influence smoking cessation among African-Americans participating in a randomized clinical trial. Soc. Sci. Med. 2012, 74(9):1394-1401. 10.1016/j.socscimed.2012.01.013.
49. McClave A.K., Dube S.R., Strine T.W., Kroenke K., Caraballo R.S., Mokdad A.H. Associations between smoking cessation and anxiety and depression among U.S. adults. Addict Behav. 2009, 34(6-7):491-497. (S0306-4603(09)00026-4 [pii]). 10.1016/j.addbeh.2009.01.005.
50. Reitzel L.R., Businelle M.S., Kendzor D.E., Li Y., Cao Y., Castro Y., et al. Subjective social status predicts long-term smoking abstinence. BMC Public Health 2011, 11:135. (1471-2458-11-135 [pii]). 10.1186/1471-2458-11-135.
51. Reitzel L.R., Mazas C.A., Cofta-Woerpel L., Li Y., Cao Y., Businelle M.S., et al. Subjective social status affects smoking abstinence during acute withdrawal through affective mediators. Addiction 2010, 105(5):928-936. 10.1111/j.1360-0443.2009.02875.x.
52. Reitzel L.R., Vidrine J.I., Businelle M.S., Kendzor D.E., Cao Y., Mazas C.A., et al. Neighborhood perceptions are associated with tobacco dependence among African-American smokers. Nicotine Tob. Res. 2012, 14(7):786-793. 10.1093/ntr/ntr285.
53. Williams D.R. Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann. N. Y. Acad. Sci. 1999, 896:173-188. 10.1111/j.1749-6632.1999.tb08114.x.
54. Al Koudsi N., Ahluwalia J.S., Lin S.K., Sellers E.M., Tyndale R.F. A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo. Pharmacogenomics J. 2009, 9(4):274-282.
55. Ho M.K., Mwenifumbo J.C., Zhao B., Gillam E.M., Tyndale R.F. A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. Pharmacogenet. Genomics 2008, 18(1):67-75.
56. Lerman C., Schnoll R.A., Hawk L.W., Cinciripini P., George T.P., Wileyto E.P., et al. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir. Med. 2015, 10.1016/S2213-2600(14)70294-2.
57. Mwenifumbo J.C., Al Koudsi N., Ho M.K., Zhou Q., Hoffmann E.B., Sellers E.M., et al. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black-African descent. Hum. Mutat. 2008, 29(5):679-688.
58. Mwenifumbo J.C., Zhou Q., Benowitz N.L., Sellers E.M., Tyndale R.F. New CYP2A6 gene deletion and conversion variants in a population of Black African descent. Pharmacogenomics 2010, 11(2):189-198.
59. CDC Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR 2009, 58(44):1227-1232.
60. Kroenke K., Spitzer R.L., Williams J.B. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med. Care 2003, 41(11):1284-1292. 10.1097/01.MLR.0000093487.78664.3C.
61. Lowe B., Kroenke K., Grafe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J. Psychosom. Res. 2005, 58(2):163-171. 10.1016/j.jpsychores.2004.09.006.
62. Department of Health and Human Services, Office of the Secretary Annual update of the HHS poverty guidelines, 42. U.S.C. 9902 (2). Fed. Regist. 2012, 77(17):4034-4035.
63. Fiore M., et al. Treating Tobacco Use and Dependence: Clinical Practice Guideline 2008 Update 2008, US Department of Health and Human Services Public Health Service.
64. Gonzales D., Rennard S.I., Nides M., Oncken C., Azoulay S., Billing C.B., et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. J. Am. Med. Assoc. 2006, 296(1):47-55.
65. Jorenby D.E., Hays J.T., Rigotti N.A., Azoulay S., Watsky E.J., Williams K.E., et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. J. Am. Med. Assoc. 2006, 296(1):56-63.
66. Nollen N.L., Cox L.S., Nazir N., Ellerbeck E.F., Owen A., Pankey S., et al. A pilot clinical trial of varenicline for smoking cessation in black smokers. Nicotine Tob. Res. 2011, 13(9):868-873. 10.1093/ntr/ntr063.
67. Ahluwalia J.S., McNagny S.E., Clark W.S. Smoking cessation among inner-city African-Americans using the nicotine transdermal patch. J. Gen. Intern. Med. 1998, 13(1):1-8.
68. Ahluwalia J.S., Harris K.J., Catley D., Okuyemi K.S., Mayo M.S. Sustained-release bupropion for smoking cessation in African-Americans: a randomized controlled trial. J. Am. Med. Assoc. 2002, 288(4):468-474. 10.1001/jama.288.4.468.
69. Petersen M.L., Wang Y., van der Laan M.J., Guzman D., Riley E., Bangsberg D.R. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin. Infect. Dis. 2007, 45(7):908-915.
70. Fiore M., Jaen C., Baker T., Bailey W., Benowitz N., Curry S., et al. Treating Tobacco Use and Dependence Clinical Practice Guideline: 2008 Update 2008, U.S. Department of Health and Human Services, Washington, DC.
71. Dorsey R., Graham G. New HHS data standards for race, ethnicity, sex, primary language, and disability status. J. Am. Med. Assoc. 2011, 306(21):2378-2379. 10.1001/jama.2011.1789.
72. Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System Survey Questionnaire 2012, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Georgia.
73. Idler E.L., Russell L.B., Davis D. Survival, functional limitations, and self-rated health in the NHANES I epidemiologic follow-up study, 1992. First National Health and Nutrition Examination Survey. Am. J. Epidemiol. 2000, 152(9):874-883.
74. Lohman T., Roche A., Martorell R. Anthropometric Standardization Reference Manual 1988, Human Kinectic Books, Champaign, IL.
75. Al-Delaimy W.K., Edland S., Pierce J.P., Mills A.L., W M.M. Technical Report on Analytic Methods and Approaches Used in the 2008 California Tobacco Survey Analysis. Data Collection Methodology 2009, vol. 1. University of California, San Diego, La Jolla, CA.
76. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) National Health and Nutrition Examination Survey 2012, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD.
77. Fagerstrom K., Russ C., Yu C.R., Yunis C., Foulds J. The fagerstrom test for nicotine dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob. Res. 2012, 14(12):1467-1473. 10.1093/ntr/nts018.
78. Hughes J.R. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob. Res. 2007, 9(3):315-327. 10.1080/14622200701188919.
79. Tiffany S.T., Wray J.M. The clinical significance of drug craving. Ann. N. Y. Acad. Sci. 2012, 1248:1-17. 10.1111/j.1749-6632.2011.06298.x.
80. Cappelleri J.C., Bushmakin A.G., Baker C.L., Merikle E., Olufade A.O., Gilbert D.G. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict. Behav. 2007, 32(5):912-923.
81. Cohen S., Williamson G. Perceived stress in a probability sample of the United States. The Social Psychology of Health 1988, 31-68. Sage, Newbury Park, CA. S. Spacapan, S. Oskamp (Eds.).
82. Sternthal MJ, Slopen N, Williams DR. Racial disparities in health. Du Bois Rev. Soc. Sci. Res. Race. 2011;8(01):95-113. doi: . doi:10.1017/s1742058x11000087.
83. Centers for Disease Control and Prevention Reactions to Race. Behavioral Risk Factor Surveillance System Survey Questionnaire 2012, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
84. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006, 166(10):1092-1097. 10.1001/archinte.166.10.1092.
85. Wilson R.S., Bennett D.A., Mendes de Leon C.F., Bienias J.L., Morris M.C., Evans D.A. Distress proneness and cognitive decline in a population of older persons. Psychoneuroendocrinology 2005, 30(1):11-17. 10.1016/j.psyneuen.2004.04.005.
86. Cook W.W., Medley D.M. Proposed hostility and pharisaic-virtue scales for the MMPI. J. Appl. Psychol. 1954, 38:414-418.
87. Adler N. Social Status Ladder. John D and Catherine T MacArthur Research Network on Socioeconomic Status and Health, (Accessed 2014 September 16). http://www.macses.ucsf.edu/research/psychosocial/subjective.php.
88. Sampson R.J., Raudenbush S.W., Earls F. Neighborhoods and violent crime: a multilevel study of collective efficacy. Science 1997, 277(5328):918-924.
89. Steptoe A., Feldman P.J. Neighborhood problems as sources of chronic stress: development of a measure of neighborhood problems, and associations with socioeconomic status and health. Ann. Behav. Med. 2001, 23(3):177-185.
90. Diener E., Emmons R., Larsen R.A., Griffin S. The satisfaction with life scale. J. Pers. Assess. 1985, 49(1).
91. Garrison G.D., Dugan S.E. Varenicline: a first-line treatment option for smoking cessation. Clin. Ther. 2009, 31(3):463-491.
92. Bureau of Labor Statistics, U.S.Department of Labor Educational attainment, employment, and unemployment among African-Americans. The Economics Daily 2015.
93. Macartney S., Bishaw A., Fontenot K. Poverty rates for selected detailed race and Hispanic groups by state and place: 2007-2011. American Community Survey Briefs 2013.
94. Brewer L.C., Carson K.A., Williams D.R., Allen A., Jones C.P., Cooper L.A. Association of race consciousness with the patient-physician relationship, medication adherence, and blood pressure in urban primary care patients. Am. J. Hypertens. 2013, 10.1093/ajh/hpt116.
95. Williams D.R., Collins C. Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep. 2001, 116(5):404-416.